首页> 外文会议>Society for Biomaterials annual meeting and exposition >HumeurVitree : Revolutionizing Retinal Detachment Surgery
【24h】

HumeurVitree : Revolutionizing Retinal Detachment Surgery

机译:HUMEURVITREE:彻底改变视网膜脱离手术

获取原文
获取外文期刊封面目录资料

摘要

We have developed a novel, patented gel whose use as a vitreous substitute has the ability to transform the retinal detachment space. The polymer is a combination of hydrophobic N-isopropyl acrylamide (NIPAM), hydrophilic polyethylene glycol (PEG) and acrylic acid (AA), and a monomer containing a hydrolysable lactone ring. Poly(NIPAM) has unique thermal properties, giving our polymer combination a lower critical solution temperature near the body's temperature of 37°C. Practically, this means our polymer is a liquid at room temperature, allowing for easy injection into the eye, and will self-assemble into a gel at body temperature in an aqueous environment, such as the vitreous space. While poly(NIPAM) is typically opaque upon gelation, our formulation including hydrophilic PEG allows the material to maintain transparency. This would allow patients to see through the material, a feature not currently available with existing vitreous tamponades. allowing them to resume normal activities shortly after surgery instead of potentially weeks of downtime. Additionally, the lactone ring incorporated into the polymer backbone aids in polymer degradation over time, allowing the gel to be naturally cleared by the eye over many months. Patients could then be treated with a single surgery, instead of the multiple surgeries currently required to place then subsequently remove the tamponade material. Furthermore, as our material has a tailorable density, the gel formulation would not require patients to be "positioned" to increase the likelihood of a successful procedure. While this is a helpful for all patients, it is especially advantageous to those with inferior retinal tears or pediatric patients. Since this material is a gel, there would also be no limitations to air travel, which again would minimize the disruption to the patient and reduce the economic costs associated with these conditions. To date, we have tested this material in animals and it shows no toxicity to the ocular tissues, allowing it to remain in the eye for many months; some current products must be removed after a few weeks due to toxicity issues.
机译:我们开发了一种新颖的专利凝胶,其用作玻璃替代品的用途具有改变视网膜脱离空间的能力。聚合物是疏水性N-异丙基丙烯酰胺(NIPAM),亲水聚乙二醇(PEG)和丙烯酸(AA)的组合,以及含有可水解内酯环的单体。聚(NIPAM)具有独特的热性能,使聚合物组合较低的临界溶液温度靠近体内的37℃。实际上,这意味着我们的聚合物在室温下是液体,允许易于注射到眼睛中,并将在含水环境中自组装成体温下的凝胶,例如玻璃体的空间。虽然聚(NIPAM)通常在凝胶化上不透明,但是我们包括亲水PEG的配方允许材料保持透明度。这将使患者能够通过材料看,该功能目前没有现有的玻璃体铺扎。允许他们在手术后不久的情况下恢复正常活动,而不是潜在的几周停机时间。另外,内酯环掺入聚合物骨架中的聚合物降解随时间劣化,允许凝胶在几个月内通过眼睛自然清除。然后可以用单个手术治疗患者,而不是目前所需的多个手术,然后随后去除局部棉签。此外,随着我​​们的材料具有可定制的密度,凝胶配方不会要求患者“定位”以增加成功程序的可能性。虽然这对所有患者有所帮助,但它对具有较差视网膜撕裂或儿科患者的人来说特别有利。由于这种材料是凝胶,因此对航空旅行的局限性也不会最大限度地减少对患者的破坏并降低与这些条件相关的经济成本。迄今为止,我们已经在动物中测试了这种材料,并且对眼部组织没有毒性,使其留在眼睛上几个月;由于毒性问题,必须在几周后删除一些目前的产品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号